Table 6.
Health Outcomes | Unit of Intake | RR (95% C.I.) | N° of Prospective Studies | References |
---|---|---|---|---|
Total Dairy Products | ||||
All-cause mortality |
Highest vs. Lowest | 1.03 (0.98–1.07) | 27 | [114] |
/ | 33 | [169] | ||
Dose-Response | 0.98 (0.93–1.03) | 16 / |
[114] [115] |
|
0.99 (0.97–1.01) | 20 | [169] | ||
Total CVDs mortality |
Highest vs. Lowest | 0.93 (0.88–0.98) | 16 | [169] |
Dose-Response | 0.98 (0.96–1.00) | 13 | ||
CHD | Highest vs. Lowest | 0.91 (0.82–1.00) | 11 | [130] |
/ | 13 | [118] | ||
Dose-Response | / | 10 / |
[118] [115] |
|
Stroke | Highest vs. Lowest | 0.79 (0.75–0.82) | 7 | [130] |
0.96 (0.90–1.01) | 12 | [118] | ||
Dose-Response | 0.98 (0.96–1.00) | 11 / |
[118] [115] |
|
HBP | Highest vs. Lowest | 0.89 (0.86–0.93) | 9 | [120] |
Dose-Response | 0.95 (0.94–0.97) | 9 | ||
CHF | Highest vs. Lowest | / | 3 | [118] |
Dose-Response | 1.08 (1.01–1.15) | 1 | ||
T2D | Highest vs. Lowest | 0.89 (0.84–0.89) | 11 | [121] |
0.92 (0.86–0.97) | 4 | [130] | ||
Dose-Response | 0.96 (0.94–0.99) | / 21 |
[115] [122] |
|
Overweight/Obesity | Highest vs. Lowest | / | 6 | [123] |
Dose-Response | 0.97 (0.93–1.01) | 5 | ||
MetS | Highest vs. Lowest | 0.75 (0.66–0.84) | 12 | [168] |
Dose-Response | 0.91 (0.85–0.96) | 9 | ||
Total cancer mortality |
Highest vs. Lowest | 1.03 (0.98–1.07) | 19 | [169] |
Dose-Response | / | 9 | ||
Total cancer incidence |
Highest vs. Lowest | 0.95 (0.90–1.00) | / | [90] |
Dose-Response | No data | |||
CRC | Highest vs. Lowest | 0.83 (0.76–0.89) | 18 | [124] |
Dose-Response | 0.93 (0.91–0.94) | 15 / |
[124] [115] |
|
0.87 (0.83–0.90) | 10 | [125] | ||
Breast cancer | Highest vs. Lowest | 0.90 (0.83–0.98) | 16 | [170] |
Dose-Response | 0.97 (0.95–0.99) a | / | ||
Gastric cancer | Highest vs. Lowest | / | 3 | [128] |
Dose-Response | No data | |||
Total Milk | ||||
All-cause Mortality |
Highest vs. Lowest | / | 27 | [169] |
Dose-Response | 1.03 (0.99–1.06) | 16 | ||
Total CVDs mortality |
Highest vs. Lowest | / | 15 | [169] |
Dose-Response | / | 9 | ||
CHD | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Stroke | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
HBP | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CHF | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
T2D | Highest vs. Lowest | No data | ||
Dose-Response | / | 10 | [122] | |
Overweight/Obesity | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
MetS | Highest vs. Lowest | 0.78 (0.69–0.87) | 7 | [168] |
Dose-Response | 0.87 (0.79–0.95) | 6 | ||
Total cancer mortality |
Highest vs. Lowest | / | 13 | [169] |
Dose-Response | 1.03 (0.99–1.06) | 8 | ||
Total cancer incidence |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CRC | Highest vs. Lowest | No data | ||
Dose-Response | 0.94 (0.92–0.96) | 9 | [125] | |
Breast cancer | Highest vs. Lowest | 0.94 (0.86–1.03) | / | [170] |
0.92 (0.84–1.02) | 18 | [127] | ||
Dose-Response | 0.97 (0.93–1.01) | 11 | ||
/ | / | [170] | ||
Gastric cancer | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Whole milk (w) and skim milk (s) | ||||
All-cause mortality |
Highest vs. Lowest | 1.15 (1.09–1.20) (W) | 9 | [169] |
/(S) | 8 | |||
Dose-Response | 1.10 (1.00–1.21) (W) | 6 | ||
/(S) | 6 | |||
Total CVDs mortality |
Highest vs. Lowest | 1.09 (1.02–1.16) (W) | 5 | [169] |
/(S) | 4 | |||
Dose-Response | /(W) | 4 | ||
/(S) | 4 | |||
CHD | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Stroke | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
HBP | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CHF | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
T2D | Highest vs. Lowest | 0.87 (0.78–0.96) (W) | 7 | [121] |
No data (S) | ||||
Dose-Response | /(W) /(S) |
9 7 |
[122] | |
Overweight/Obesity | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
MetS | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Total cancer mortality |
Highest vs. Lowest | 1.17 (1.08–1.28) (W) | 7 | [169] |
/(S) | 7 | |||
Dose-Response | 1.13 (1.01–1.28) (W) | 6 | ||
/(S) | 6 | |||
Total cancer incidence |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CRC | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Breast cancer | Highest vs. Lowest | /(W) | 7 9 |
[170] [127] |
0.93 (0.84–1.02) (S) | 6 | [170] | ||
0.93 (0.85–1.00) (S) | 8 | [127] | ||
Dose-Response | /(W) | 5 | ||
0.96 (0.92–1.00) (S) | 5 | |||
Gastric cancer | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Yogurt | ||||
All-cause mortality |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Total CVDs mortality |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CHD | Highest vs. Lowest | / | 5 | [171] |
Dose-Response | No data | |||
Stroke | Highest vs. Lowest | / | 5 | [171] |
Dose-Response | No data | |||
HBP | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CHF | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
T2D | Highest vs. Lowest | 0.83 (0.70–0.98) | 7 | [121] |
Dose-Response | 0.94 (0.91–0.98) | 11 | [122] | |
Overweight/Obesity | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
MetS | Highest vs. Lowest | 0.77 (0.66–0.88) | 3 | [168] |
Dose-Response | 0.82 (0.73–0.91) | 3 | ||
Total cancer mortality |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Total cancer incidence |
Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
CRC | Highest vs. Lowest | No data | ||
Dose-Response | No data | |||
Breast cancer | Highest vs. Lowest | 0.91 (0.83–0.99) | 7 | [170] |
0.90 (0.82–1.00) | 5 | [127] | ||
Dose-Response | / | 3 | ||
Gastric cancer | Highest vs. Lowest | No data | ||
Dose-Response | No data |
a Serving/day compared with no dairy product consumption.